Patent · US Expired

Method of inhibiting mammalian topoisomerase II and malignant cell growth in mammals, with substituted (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4 ]-benzoxazine(and-benzothiazine)-6-carboxylic acids

US5308843A · kind A · utility

1Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 1990
Grant dateMay 3, 1994
Priority date
Expiry dateSep 11, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of inhibiting mammalian topoisomerase II and inhibiting the growth and inducing the regression of malignant cells in mammals by the action of a (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine or -benzothiazine of the formula ##STR1## wherein R.sub.1 is hydrogen or fluoro, R.sub.2 and R.sub.3 each independently is hydrogen or alkyl having 1 to 4 carbon atoms, and X is O, S or S=O; a pharmaceutically acceptable acid-addition salt thereof; or a salt thereof with a pharmaceutically acceptable cation; and certain novel compounds of formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.